Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2007 1
2011 1
2012 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 1
2020 2
2021 1
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Preomic profile of BxPC-3 cells after treatment with BRC4.
Previtali V, Myers SH, Poppi L, Wynne K, Casamassima I, Girotto S, Di Stefano G, Farabegoli F, Roberti M, Oliviero G, Cavalli A. Previtali V, et al. Among authors: farabegoli f. J Proteomics. 2023 Sep 30;288:104983. doi: 10.1016/j.jprot.2023.104983. Epub 2023 Aug 1. J Proteomics. 2023. PMID: 37536521
EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.
Farooqi AA, Pinheiro M, Granja A, Farabegoli F, Reis S, Attar R, Sabitaliyevich UY, Xu B, Ahmad A. Farooqi AA, et al. Among authors: farabegoli f. Cancers (Basel). 2020 Apr 12;12(4):951. doi: 10.3390/cancers12040951. Cancers (Basel). 2020. PMID: 32290543 Free PMC article. Review.
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells.
Rossi V, Govoni M, Farabegoli F, Di Stefano G. Rossi V, et al. Among authors: farabegoli f. Biochim Biophys Acta Gen Subj. 2022 Sep;1866(9):130185. doi: 10.1016/j.bbagen.2022.130185. Epub 2022 Jun 3. Biochim Biophys Acta Gen Subj. 2022. PMID: 35661802
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.
Falchi F, Giacomini E, Masini T, Boutard N, Di Ianni L, Manerba M, Farabegoli F, Rossini L, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Roberti M, Pellicciari R, Cavalli A. Falchi F, et al. Among authors: farabegoli f. ACS Chem Biol. 2017 Oct 20;12(10):2491-2497. doi: 10.1021/acschembio.7b00707. Epub 2017 Sep 1. ACS Chem Biol. 2017. PMID: 28841282 Free article.
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination.
Schipani F, Manerba M, Marotta R, Poppi L, Gennari A, Rinaldi F, Armirotti A, Farabegoli F, Roberti M, Di Stefano G, Rocchia W, Girotto S, Tirelli N, Cavalli A. Schipani F, et al. Among authors: farabegoli f. Int J Mol Sci. 2022 Jul 28;23(15):8338. doi: 10.3390/ijms23158338. Int J Mol Sci. 2022. PMID: 35955488 Free PMC article.
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
Roberti M, Schipani F, Bagnolini G, Milano D, Giacomini E, Falchi F, Balboni A, Manerba M, Farabegoli F, De Franco F, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Girotto S, Pellicciari R, Cavalli A. Roberti M, et al. Among authors: farabegoli f. Eur J Med Chem. 2019 Mar 1;165:80-92. doi: 10.1016/j.ejmech.2019.01.008. Epub 2019 Jan 10. Eur J Med Chem. 2019. PMID: 30660828
22 results